[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 300
Citations 0
Comment & Response
August 2016

Proton Pump Inhibitors and Dementia Incidence

Author Affiliations
  • 1Department of Critical Care, Mayo Clinic, Jacksonville, Florida
  • 2Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida
  • 3Department of Neurology, Mayo Clinic, Jacksonville, Florida
JAMA Neurol. 2016;73(8):1026-1027. doi:10.1001/jamaneurol.2016.1503

To the Editor I read with interest the article by Gomm et al1 investigating the association of proton pump inhibitors and dementia. The authors are to be commended for their large data set, analysis, and detailed proposed pathophysiologic mechanism by which this association might occur. However, 2 important medical comorbidities seem to be missing from their study: gastroesophageal reflux disease and obstructive sleep apnea. Both of these comorbidities can cause cognitive issues, especially in those with apolipoprotein E genetic variants2 and those who have had a stroke. Gastroesophageal reflux disease would constitute the reason patients took a proton pump inhibitor but could also be a surrogate for obesity, increased body mass index, and comorbid obstructive sleep apnea. Obstructive sleep apnea is a known risk factor for nocturnal hypoxic episodes and could, in theory, be covariate to help explain why this association may be statistically present.

First Page Preview View Large
First page PDF preview
First page PDF preview